OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells presents a paramount challenge to the biopharmaceutical industry. Multiple strategies can be employed to antibody titer, such as process parameter optimization, media optimization, and the use of perfusion technologies. Fine-tuning media composition plays a c